Magnetic bypass: a new tool against obesity and diabetes?

NCT ID NCT06467955

Ongoing Disease control Sponsor: GT Metabolic Solutions, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new magnetic device (MagDI System) that creates a connection between the duodenum and ileum, bypassing part of the small intestine. The goal is to help with weight loss and blood sugar control in 60 adults with obesity and type 2 diabetes. Researchers are checking if the procedure is safe and works as intended.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Magnetic compression device (MagDI System) to create a small bowel bypass
What this could lead to: If successful, this could offer a less invasive surgical option for weight loss and type 2 diabetes control.
What could go wrong: This is an early feasibility study with only 60 participants. The device may fail to create a lasting bypass, or serious complications like bowel perforation or obstruction could occur.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBESITY TYPE 2 DIABETES

Contacts and locations

Locations

McGill University

Montreal, Quebec, H3A 0G4, Canada
University of Toronto

Toronto, Ontario, Canada
Westmount Square Surgical Center

Westmount, Quebec, H3Z 2P9, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.